Who Owns Zyn? A Look into the Swedish Match and Philip Morris International Connection
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Always consult a healthcare professional before making changes to your health routine. If you're experiencing a medical emergency, call 911 or your local emergency number.
Read our full medical disclaimer →Who Owns Zyn?
Zyn is owned by Philip Morris International (PMI). PMI acquired Swedish Match, Zyn’s original parent company, in November 2022 for approximately $16 billion. Swedish Match developed Zyn from scratch and built it into the dominant US nicotine pouch brand before PMI stepped in.
If you’ve wondered whether that little tin has Big Tobacco fingerprints on it, the answer is yes. Marcus, a former 22-year Marlboro Red smoker from Tulsa who used Zyn while stepping down his nicotine use, put it plainly: “I wasn’t thrilled when I found out PMI bought Swedish Match. But the pouch doesn’t care who signs the checks, and it still worked the same.”
Swedish Match: Where Zyn Started
Swedish Match created Zyn as a tobacco-leaf-free alternative to traditional snus. The company had deep roots in Scandinavian smokeless tobacco, and they spotted the American demand for something more discreet and less messy than dip or cigarettes.
Under Swedish Match, Zyn grew fast. By the early 2020s, it had captured roughly 75% of the US nicotine pouch market. That growth came from smart retail placement, a wide range of flavors and strengths, and entering the US market right as smokers were looking for exits. Swedish Match kept Zyn tobacco-leaf-free, which helped it secure FDA authorization for US sale and made the whole company an attractive acquisition target.
Philip Morris International Takes Over
PMI completed its Swedish Match acquisition in November 2022. The $16 billion price tag made it one of the largest tobacco-adjacent deals in recent memory.
PMI makes Marlboro cigarettes outside the United States and IQOS heated tobacco products. The company has been publicly pushing a “smoke-free future” strategy for years, and acquiring Zyn was central to that pivot. Cigarette volumes keep declining in developed markets, and PMI needed a product that was growing, not shrinking.
The deal handed PMI Zyn’s US retail infrastructure, Swedish Match’s European snus business, and a brand with near-category-dominance. For PMI, Zyn wasn’t just a product. It was a hedge.
What PMI Ownership Means for Zyn Users
Day-to-day, nothing changed for users. The ingredients inside each Zyn pouch stayed the same. The 3mg and 6mg strength options didn’t shift. Manufacturing stayed in the US.
What changed is the corporate context. PMI’s resources mean more global distribution and more R&D investment behind the brand. That’s likely good for availability and product innovation. It also means Zyn now carries the reputation of a company that spent decades pushing cigarettes worldwide, which is a fair criticism.
Regulatory pressure has increased. Health advocates have raised real questions about nicotine pouch safety and marketing practices, especially around youth access. With PMI’s resources come PMI’s scrutiny.
| Factor | Swedish Match Era | PMI Era |
|---|---|---|
| Ownership | Independent Swedish company | Subsidiary of global tobacco giant |
| US Market Share | ~75% of nicotine pouches | Maintained dominant position |
| Distribution | US-focused | Global expansion push |
| R&D Investment | Oral nicotine innovation | Broad “smoke-free” portfolio |
| Regulatory Optics | Smaller independent brand | Major tobacco company scrutiny |
The Bigger Picture
Zyn’s ownership shift reflects what’s happening across the nicotine industry. Big tobacco companies are pouring money into pouches, heated tobacco, and vaping products because combustible cigarette sales keep falling in markets like the US and Western Europe.
Whether that’s genuine harm reduction or just a new vehicle for nicotine dependency is a legitimate debate. Both things can be true at once. Knowing how nicotine pouches got here gives you better context for making your own call, whether you’re using Zyn as a quit tool or trying to understand what you’re putting in your body.